• [email protected]
  • +971 507 888 742
Submit Manuscript
SciAlert
  • Home
  • Journals
  • Information
    • For Authors
    • For Referees
    • For Librarian
    • For Societies
  • Contact
  1. Journal of Biological Sciences
  2. Vol 10 (6), 2010
  3. 507-513
  • Online First
  • Current Issue
  • Previous Issues
  • More Information
    Aims and Scope Editorial Board Guide to Authors Article Processing Charges
    Submit a Manuscript

Journal of Biological Sciences

Year: 2010 | Volume: 10 | Issue: 6 | Page No.: 507-513
DOI: 10.3923/jbs.2010.507.513

Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail

Article Trend



Total views 92

Authors


F. Irshaid

Country: Jordan

A. Jaran

Country: Jordan

F. Dilmi

Country: Jordan

K. Tarawneh

Country: Jordan

R. Hadeth

Country: Jordan

Ahad Al- Khatib

Country: Jordan

Keywords


  • Expression
  • hematoxylin
  • infection
  • malignant
  • oncogene
Research Article

Prevalence of Epstein-Barr Virus Latent Membrane Protein-1 in Jordanian Patients with Hodgkin’s Lymphoma and Non-Hodgkin’s Lymphoma

F. Irshaid, A. Jaran, F. Dilmi, K. Tarawneh, R. Hadeth and Ahad Al- Khatib
The aim of this study was to estimate the frequency of EBV infection in Hodgkin’s Lymphoma (HL) and Non-Hodgkin’s Lymphoma (NHL) occurring in Jordanian patients. A total of 55 patients with lymphoma were examined. The diagnosis was confirmed by staining the slides of these cases with hematoxylin and eosin. The presence of EBV was detected by immunostating for expression of latent membrane protein-1 (LMP-1). Of 55 patients, 31 and 25 were diagnosed as HL and NHL, respectively. The majority of the HL cases exhibited Mixed Cellularity (MC) subtype. The high grade was found to be the commonest subtype of NHL. The frequency of LMP-1 expression occurred more frequent in patients with HL (60.0%) than in patients with NHL (32.0%). The frequency of LMP-1 expression was higher in patients with MC subtype (61.11%) than in patients with nodular sclerosis (28.57%). No age or gender difference in occurrence of EBV infection was observed among HL patients. By contrast, the frequency of LMP-1 expression in NHL patients aged below 50 was lower (16.66%) than in NHL patients aged 50 or above (46.15%). In addition, EBV infection was more frequent in females with NHL (38.46%) than in male with NHL (25%). In NHL cases, the frequency of LMP-1 expression in intermediate grade (60.0%) was high compared to low (37.5%) or high grades (16.7%). Therefore, analysis of LMP-1 expression suggests an important role for this viral oncogene in the pathogenesis of EBV-associated malignant lymphomas. These data support the previous findings that people with EBV may develop lymphoma and that efforts to maintain low lymphoma should be considered for people with EBV infection.
PDF Fulltext XML References Citation

How to cite this article

F. Irshaid, A. Jaran, F. Dilmi, K. Tarawneh, R. Hadeth and Ahad Al- Khatib, 2010. Prevalence of Epstein-Barr Virus Latent Membrane Protein-1 in Jordanian Patients with Hodgkin’s Lymphoma and Non-Hodgkin’s Lymphoma. Journal of Biological Sciences, 10: 507-513.

DOI: 10.3923/jbs.2010.507.513

URL: https://scialert.net/abstract/?doi=jbs.2010.507.513

Related Articles

Detection of Epstein Barr Virus among Benign and Malignant Breast Tumors

Leave a Comment


Your email address will not be published. Required fields are marked *

Useful Links

  • Journals
  • For Authors
  • For Referees
  • For Librarian
  • For Socities

Contact Us

Office Number 1128,
Tamani Arts Building,
Business Bay,
Deira, Dubai, UAE

Phone: +971 507 888 742
Email: [email protected]

About Science Alert

Science Alert is a technology platform and service provider for scholarly publishers, helping them to publish and distribute their content online. We provide a range of services, including hosting, design, and digital marketing, as well as analytics and other tools to help publishers understand their audience and optimize their content. Science Alert works with a wide variety of publishers, including academic societies, universities, and commercial publishers.

Follow Us
© Copyright Science Alert. All Rights Reserved